Phase 1 1 trial
Phase 1
NCT04530604 Oct 2020 → Mar 2021 COVID-19 , acute respiratory distress syndrome Gregory Yanik
Completed
No outcome recorded
Phase 1/2 1 trial
Phase 1/2
NCT00406978 Feb 2006 → Sep 2010 plasma cell myeloma Silvio Aime
Completed
No outcome recorded
Phase 2 13 trials
Phase 2
NCT06182410 Aug 2024 → May 2027 neuroblastoma , thrombotic microangiopathy University of California, San Francisco
Withdrawn
No outcome recorded
Phase 2
NCT05987124 Mar 2024 → Aug 2027 expected hepatic veno-occlusive disease New York Medical College
Recruiting
No outcome recorded
Phase 2
NCT04313036 Mar 2021 → May 2022 disease related to hematopoietic stem cell transplant , hepatic veno-occlusive disease Loyola University
Unknown
No outcome recorded
Phase 2
NCT04777422 Feb 2021 → Oct 2023 Kawasaki disease New York Medical College
Unknown
No outcome recorded
Phase 2
NCT04652115 Jan 2021 → Dec 2026 expected COVID-19 Brigham and Women's Hospital
Recruiting
No outcome recorded
Phase 2
NCT04335201 May 2020 → Apr 2021 —
IRCCS San Raffaele
Completed
No outcome recorded
Phase 2
NCT04348383 Apr 2020 → Feb 2023 COVID-19 Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Completed
No outcome recorded
Phase 2
NCT03954106 Oct 2019 → Sep 2020 diffuse large B-cell lymphoma , toxic encephalopathy Jazz Pharmaceuticals
Terminated
No outcome recorded
Phase 2
NCT03384693 May 2018 → Jul 2020 thrombotic microangiopathy University of California, San Francisco
Completed
No outcome recorded
Phase 2
NCT03339297 Feb 2018 → May 2020 acute graft versus host disease Jazz Pharmaceuticals
Completed
No outcome recorded
Phase 2
NCT03805581 Jan 2018 → Jul 2022 acute chest syndrome , sickle cell disease New York Medical College
Completed
No outcome recorded
Phase 2
NCT02675959 Jul 2017 → Dec 2026 expected sickle cell disease New York Medical College
Recruiting
No outcome recorded
Phase 2
NCT00003966 Apr 2000 → Feb 2006 hepatic veno-occlusive disease Dana-Farber Cancer Institute
Completed
No outcome recorded
Show 3 more trials Phase 3 3 trials
Phase 3
NCT02851407 Sep 2016 → Oct 2020 hepatic veno-occlusive disease Jazz Pharmaceuticals
Completed
No outcome recorded
Phase 3
NCT00628498 Dec 2007 → Jul 2016 hepatic veno-occlusive disease Jazz Pharmaceuticals
Completed
No outcome recorded
Phase 3
NCT00358501 Jul 2006 → Sep 2008 hepatic veno-occlusive disease Jazz Pharmaceuticals
Completed
No outcome recorded
Phase 4 1 trial
Phase 4
NCT02876601 Apr 2017 → Feb 2018 —
Medical University of Vienna
Completed
No outcome recorded
Phase not stated 2 trials
— NCT00263978 Nov 2005 → Jun 2009 liver disorder Emory University
No longer available
No outcome recorded
— NCT00143546 Nov 2003 → ? hepatic veno-occlusive disease St. Jude Children's Research Hospital
No longer available
No outcome recorded